XML 48 R37.htm IDEA: XBRL DOCUMENT
v3.25.2

Organization and Nature of Operations - Schedule of Company’s Subsidiaries Which are Included in Condensed Consolidated Financial Statements (Details) | 6 Months Ended
--- | ---
Jun. 30, 2025
Avalon Healthcare System, Inc. (“AHS”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Delaware May 18, 2015
Percentage of Ownership | 100.00%
Principal Activities | Holding company for payroll and other expenses
Avalon RT 9 Properties LLC (“Avalon RT 9”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | New Jersey February 7, 2017
Percentage of Ownership | 100.00%
Principal Activities | Owns and operates an income-producing real property and holds and manages the corporate headquarters
Avalon (Shanghai) Healthcare Technology Co., Ltd. (“Avalon Shanghai”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | PRC April 29, 2016
Percentage of Ownership | 100.00%
Principal Activities | Not considered an operating entity
Genexosome Technologies Inc. (“Genexosome”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Nevada July 31, 2017
Percentage of Ownership | 60.00%
Principal Activities | No current activities to report; dormant
Avactis Biosciences Inc. (“Avactis”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Nevada July 18, 2018
Percentage of Ownership | 60.00%
Principal Activities | Dormant; in process of being dissolved
Avactis Nanjing Biosciences Ltd. (“Avactis Nanjing”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | PRC May 8, 2020
Percentage of Ownership | 100.00%
Principal Activities | Dormant; in process of being dissolved
Avalon Laboratory Services, Inc. (“Avalon Lab”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Delaware October 14, 2022
Percentage of Ownership | 100.00%
Principal Activities | No current activities to report; dormant
Q&A Distribution LLC (“Q&A Distribution”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | Texas May 1, 2024
Percentage of Ownership | 100.00%
Principal Activities | Distributes KetoAir device
Nexus MergerSub Limited (“Nexus”) [Member] |
Schedule of Company’s Subsidiaries which are Included in Condensed Consolidated Financial Statements [Line Items] |
Place and Date of Incorporation | BVI February 21, 2025
Percentage of Ownership | 100.00%
Principal Activities | No current activities to report

X
- Definition Place and date in which the subsidiary of the limited liability company or limited partnership was organized. + References No definition available. + Details
Name: | avco_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPlaceAndDateOfIncorporation
Namespace Prefix: | avco_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of business purpose of the subsidiary of the limited liability company or limited partnership, for example, its day-to-day operating functions and whether it acts as a holding or operating company. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipBusinessPurpose
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of units or percentage investment held in the subsidiary by the limited liability company or limited partnership. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipOwnershipInterest
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonHealthcareSystemIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonRT9PropertiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonShanghaiHealthcareTechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_GenExosomeTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvactisBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvactisNanjingBiosciencesLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_AvalonLaboratoryServicesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_QADistributionLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=avco_NexusMergerSubLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |